Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity.
about
The crucial role of divalent metal ions in the DNA-acting efficacy and inhibition of the transcription of dimeric chromomycin A3Block copolymer cross-linked nanoassemblies improve particle stability and biocompatibility of superparamagnetic iron oxide nanoparticlesPhoto-inducible crosslinked nanoassemblies for pH-controlled drug releaseAlternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models.Semi-synthetic mithramycin SA derivatives with improved anticancer activity.Dimerization and DNA recognition rules of mithramycin and its analoguesMagnetic and pH dual-responsive mesoporous silica nanocomposites for effective and low-toxic photodynamic therapy.Preparation and Evaluation of PLGA-Coated Capsaicin Magnetic Nanoparticles.Tumor-preferential sustained drug release enhances antitumor activity of block copolymer micelles.Pharmaceutical differences between block copolymer self-assembled and cross-linked nanoassemblies as carriers for tunable drug release.Comparison of Dialysis- and Solvatofluorochromism-Based Methods to Determine Drug Release Rates from Polymer Nanoassemblies.
P2860
Q28483713-B9B2612B-19CE-48B5-984E-40D69D08F480Q30574016-2718E4FB-2906-44AF-B65E-96E775513E3EQ33573812-8AAB0244-4E7D-4165-92F3-B1B6BAA6A7EAQ36715672-586404D8-9484-4E95-A410-E26EC976507EQ36794596-B3283B34-78F7-492C-AEDE-A1B3F6566A2BQ36921182-FCD91CBE-DFF0-42CC-810C-BECDE614FA62Q38706089-E69861D8-9938-4F59-BB7A-6208A24C4FE2Q38888274-DCB860B0-9BB3-468F-8B12-7FCAE8E35838Q39001276-8DA5494D-0053-491A-B9EE-40D229256DE8Q39262135-BD238911-FEED-4F91-A372-572A471810C4Q48206992-9615A4DE-1DCC-4DAE-A0DA-725737A85978
P2860
Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity.
@ast
Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity.
@en
type
label
Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity.
@ast
Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity.
@en
prefLabel
Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity.
@ast
Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity.
@en
P2093
P2860
P356
P1476
Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity.
@en
P2093
Daniel Scott
Jürgen Rohr
Younsoo Bae
P2860
P304
P356
10.2147/IJN.S25427
P407
P577
2011-11-08T00:00:00Z